Medexus Submits Application to List on the Nasdaq

Medexus Submits Application to List on the Nasdaq
TORONTO – Medexus Pharmaceuticals Inc. (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has submitted its application to list on The Nasdaq Capital Market. Ken d’Entremont, Chief Executive Officer of Medexus, commented, “The submission of our application to list on the Nasdaq marks a significant milestone for Medexus. We believe we now meet the initial listing requirements, which reflects... Read More

Graphene-based sensors being developed to detect disease

Graphene-based sensors being developed to detect disease
  ADELAIDE – Based in Adelaide, South Australia, Sparc Technologies Limited has partnered with the University of Adelaide to develop non-invasive sensing devices to detect disease in humans and animals. Sparc’s new graphene biomedical division will research graphene-based sensing devices used to detect volatile organic compounds (VOCs). VOCs are understood to be indicators of disease and are present in exhaled... Read More

Relay Medical and Glow LifeTech report on successful phase II clinical results for COVID-19 treatment

Relay Medical and Glow LifeTech report on successful phase II clinical results for COVID-19 treatment
  TORONTO – Relay Medical Corp. (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, and Glow LifeTech Ltd. a private company in which Relay holds a significant equity interest, today reported on developments related to Glow’s MyCell Technology™. Glow LifeTech partner Swiss Pharmacan AG, and MGC Pharma have announced the full results of Phase II double-blind, placebo-controlled... Read More

Pure Extracts outlines study on psilocybin oral tablets, capsules and nasal gel

Pure Extracts outlines study on psilocybin oral tablets, capsules and nasal gel
VANCOUVER – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) a plant-based extraction company, reported that it has delineated the timetable and milestones for its study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at... Read More

Betting on the booming plant protein food market

Betting on the booming plant protein food market
  HALIFAX – Think plant protein is just a passing fad? Think again. You likely noticed that the plant-based counter at your favourite grocery store is growing. There’s good reason: people are buying. Despite the COVID-19 pandemic and the chaos surrounding containment and vaccination rules, consumers are quietly enjoying products made from plant proteins and milk alternatives. According to recent... Read More

Canadian IPO market surpasses $5 billion in 2020

Canadian IPO market surpasses $5 billion in 2020
  VANCOUVER – The Canadian IPO market in 2020 generated proceeds in excess of $5 billion for the year, despite fewer new issuances than in previous years. This is five times the value of offerings completed in 2019. Despite a year marked by the COVID-19 pandemic and amid economic uncertainty, the capital markets were extremely robust. In the fourth quarter... Read More

Pure Extracts Now Listed on the OTC Markets Under the Symbol PRXTF

Pure Extracts Now Listed on the OTC Markets Under the Symbol PRXTF
VANCOUVER – Pure Extracts Technologies Corp. (CSE: PULL)(OTC: PRXTF)(XFRA: A2QJAJ), a plant-based extraction, cannabis and psychedelics company, received trading approval from OTC Markets and is now trading on the OTC Market under the ticker symbol PRXTF. Pure Extracts CEO, Ben Nikolaevsky, remarked, “Trading under the new OTC ticker symbol PRXTF and applying for DTC eligibility is a major step forward... Read More

Next Green Wave Finalizes Agreement With COOKIES

Next Green Wave Finalizes Agreement With COOKIES
  VANCOUVER – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) announced they have signed a 2 year supply and production agreement with cannabis brand, COOKIES. COOKIES has 26 total retail stores in operation which includes; 17 retail stores in California, 6 retail stores across the U.S., and 3 international stores (in Barcelona and Tel Aviv). The partnership will... Read More

BetterLife Files Patent Utilizing Psychedelic Derivative

BetterLife Files Patent Utilizing Psychedelic Derivative
VANCOUVER – BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, announced it has applied for patent protection of new 2-Bromo-LSD formulations and their use in the treatment of depression and mood disorders. 2-Bromo-LSD is a nontoxic second-generation LSD-derived molecule that mimics the therapeutic potential of LSD, without the psychedelic effects or hallucinations. BetterLife’s... Read More

ZEN Graphene up 40% on test update

ZEN Graphene up 40% on test update
  VANCOUVER – ZEN Graphene Solutions Ltd. shares gained almost 40% in active trading Tuesday, December 29 after the company released more test results on a potential graphene-based antibiotic, antiviral and antifungal compound. Previous test results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto, Ontario, showed that this patent-pending formulation could be a medical breakthrough... Read More